Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4

Archives of Biochemistry and Biophysics

Volumn 359, Issue 1, 1998, Pages 89-98

  Jin, Rongyu ^a   Koop, Dennis R ^b   Raucy, Judy L ^c   Lasker, Jerome M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c AGOURON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYLEUKOTRIENE B4; ARACHIDONIC ACID; CYTOCHROME P450 4F2; GENE PRODUCT; LAURIC ACID; LEUKOTRIENE B4; PALMITIC ACID; POLYCLONAL ANTIBODY; POLYCLONAL ANTIBODY CYP4F2; PROSTAGLANDIN A1; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CHEMICAL REACTION KINETICS; ENZYME PURIFICATION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYLATION; IMMUNOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; LIVER METABOLISM; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0032213301     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1998.0880     Document Type: Article

References (49)

1. Ford-Hutchinson A. W., Gresser M., Young R. N. Annu. Rev. Biochem. 63:1994;383-417.
2. Samuelsson B., Dahlen S. E., Lindgren J. A., Rouzer C. A., Serhan C. N. Science. 237:1987;1171-1176.
3. Ford-Hutchinson A. W. Crit. Rev. Immunol. 10:1990;1-11.
4. Jubiz W., Radmark O., Malmsten C., Hansson G., Lindgren J. A., Palmblad J., Uden A. M., Samuelsson B. J. Biol. Chem. 257:1982;6106-6110.
5. Jedlitschky G., Huber M., Volkl A., Muller M., Leier I., Muller J., Lehmann W. D., Fahimi H. D., Keppler D. J. Biol. Chem. 266:1991;24763-24772.
6. Shak S., Goldstein I. M. J. Clin. Invest. 76:1985;1218-1228.
7. Sumimoto H., Takeshige K., Minakami S. Eur. J. Biochem. 172:1988;315-324.
8. Sumimoto H., Kikuta Y., Kusunose E., Kusunose M., Minakami S. Biochem. Int. 20:1990;381-387.
9. Kikuta Y., Kusonose E., Endo K., Yamamoto S., Sogawa K., Fujii-Kuriyama Y., Kusonose M. J. Biol. Chem. 268:1993;9376-9380.
10. Hankin J. A., Clay C. E., Murphy R. C. J. Pharmacol. Exp. Ther. 285:1998;155-161.
11. Mukhtar H., Khan W. A., Bik D. P., Das M., Bickers D. R. Xenobiotica. 19:1989;151-159.
12. Leier I., Muller M., Jedlitschky G., Keppler D. Eur. J. Biochem. 209:1992;281-289.
13. Shirley M. A., Murphy R. C. J. Biol. Chem. 265:1990;16288-16295.
14. Hagmann W., Korte M. Biochem. J. 267:1990;467-470.
15. Romano M. C., Eckhardt R. D., Bender P. E., Leonard T. B., Straub K. M., Newton J. F. J. Biol. Chem. 262:1987;1590-1595.
16. Sumimoto H., Kusonose E., Gotoh Y., Kusonose M., Minakami S. J. Biochem. (Tokyo). 108:1990;215-221.
17. Kikuta Y., Kusunose E., Kondo T., Yamamoto S., Kinoshita H., Kusonose M. FEBS Lett. 348:1994;70-74.
18. Chen L., Hardwick J. P. FASEB J. 8:1994;A1257.
19. Raucy J. L., Lasker J. M. Methods Enzymol. 206:1991;577-587.
20. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Anal. Biochem. 150:1985;76-85.
21. Omura T., Sato R. J. Biol. Chem. 239:1964;2370-2378.
22. Lasker J. M., Wester M. R., Aramsombatdee E., Raucy J. L. Arch. Biochem. Biophys. 353:1998;16-28.
23. Powell P. K., Wolf I., Lasker J. M. Arch. Biochem. Biophys. 335:1996;219-226.
24. Yun C.-H., Shimada T., Guengerich F. P. Mol. Pharmacol. 40:1991;679-685.
25. Powell P. K., Wolf I., Jin R., Lasker J. M. J. Pharmacol. Exp. Ther. 285:1998;1327-1336.
26. Tsutsumi M., Lasker J. M., Shimizu M., Rosman A. S., Lieber C. S. Hepatology. 10:1989;437-446.
27. McKinney M. M., Parkinson A. J. Immunol. Methods. 96:1987;271-278.
28. Carpenter S. P., Lasker J. M., Raucy J. L. Mol. Pharmacol. 49:1996;260-268.
29. Feierman D. E., Lasker J. M. Drug Metab. Dispos. 24:1996;932-939.
30. Gotoh Y., Sumimoto H., Takeshige K., Minakami S. Biochem. Biophys. Acta. 960:1988;342-350.
31. Palmer C. N. A., Richardson T. H., Griffin K. J., Hsu M.-H., Muerhoff A. S., Clark J. E., Johnson E. F. Biochem. Biophys. Acta. 1172:1993;161-166.
32. Newton D. J., Wang E. W., Lu A. Y. H. Drug Metab. Dispos. 23:1995;154-158.
33. Okita R. T., Okita J. R. Arch. Biochem. Biophys. 294:1992;1475-1481.
34. Kikuta Y., Kusonose E., Okumoto T., Kubota I., Kusunose M. J. Biochem. (Tokyo). 107:1990;280-286.
35. Kawashima H., Kusunose E., Kikuta Y., Kinoshita H., Tanaka S., Yamamoto S., Kishimoto T., Kusonose M. J. Biochem. (Tokyo). 116:1994;74-80.
36. Kawashima H., Kusunose E., Kubota I., Maekawa M., Kusunose M. Biochem. Biophys. Acta. 1123:1992;156-162.
37. Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W. Pharmacogenetics. 6:1996;1-42.
38. Imaoka S., Ogawa H., Kimura S., Gonzalez F. J. DNA Cell Biol. 12:1993;893-899.
39. Lasker J. M., Raucy J. L., Daikh B. E., Aramsombatdee E., Koop D. R. Proc. 10th Int. Symp. on Microsomes and Drug Oxidations. 10:1994;282.
40. Devchand P., Keller H., Peters J., Vazquez M., Gonzalez F., Wahli W. Nature. 384:1996;39-43.
41. Gibson G. Ann. N. Y. Acad. Sci. 804:1996;328-365.
42. Sharma R. K., Doig M. V., Lewis D. F., Gibson G. G. Biochem. Pharmacol. 38:1989;3621-3629.
43. Bichet N., Cahard D., Fabre G., Remandet B., Gouy D., Cano J. P. Toxicol. Appl. Pharmacol. 106:1990;509-517.
44. Blaauboer B. J., van Holsteijn C. W., Bleumink R., W.C. M., van Pelt F. N., Yap S. H., van Pelt J. F., van Iersel A. A., Timmerman A., Schmid B. P. Biochem. Pharmacol. 40:1990;521-528.
45. Lake B. Annu. Rev. Pharmacol. Toxicol. 35:1995;483-507.
46. Palmer C. N. A., Hsu M. H., Griffin H. K., Raucy J. L., Johnson E. F. Mol. Pharmacol. 53:1997;14-22.
47. Shimojo N., Ishizaki T., Imaoka S., Funae Y., Fujii S., Okuda K. Biochem. Pharmacol. 46:1993;621-627.
48. Imaoka S., Funae Y. Biochem. Biophys. Acta. 1074:1991;209-213.
49. Ferguson N., Donahue B., Tenney K., Morgan E. Drug Metab. Dispos. 21:1993;745-756.